Fresenius | FRE - Pre Tax Profit


Fresenius reported EUR535M in Pre-Tax Profit for its fiscal quarter ending in June of 2026.





Pre Tax Profit Change Date
Akzo Nobel EUR 148M 598M Mar/2026
Alcon AG USD 240M 24M Mar/2026
AstraZeneca USD 4.81B 894M Jun/2026
BASF EUR 1.1B 25M Mar/2026
Bayer EUR 321M 2.67B Jun/2026
Beiersdorf EUR 408.5M 43.5M Jun/2025
DaVita Healthcare Partners USD 435.01M 93.78M Jun/2026
Demant DKK 1.64B 173M Dec/2025
E.ON EUR 3.63B 2.44B Mar/2026
Essilor EUR 2.64B 196M Jun/2026
Fresenius EUR 535M 42M Jun/2026
Fresenius Medical Care EUR 383M 43M Jun/2026
Getinge SEK 428M 1.54B Mar/2025
Givaudan CHF 642M 292M Dec/2024
GlaxoSmithKline GBP 2.68B 532M Jun/2026
GN Store Nord DKK -281M 280M Jun/2026
GRIFOLS EUR 247M 135M Jun/2026
Hikma Pharmaceutical USD 147.5M 3.5M Jun/2025
Lonza CHF 624M 197M Dec/2024
Merck EUR 869M 468M Mar/2026
Novartis USD 4.27B 430M Jun/2026
Philips EUR 546M 356M Jun/2026
Roche Holding CHF 11.17B 6.38B Jun/2026
RWE EUR 150M 677M Mar/2026
Sanofi EUR 837M 1.17B Jun/2026
Smith & Nephew USD 469M 70M Dec/2025